Evaluating the validity of a bedside method of detecting hypoglycemia in children

Jerome Boluwaji Elutayo Elusiyan1, Olugbenga O Adeodu, Ebunoluwa A Adejuyigbe

  • 1Department of Pediatrics and Child Health, Obafemi Awolowo University, Ile-Ife, Nigeria. bimbolabanks@yahoo.com

Insights

The glucometer accurately assesses pediatric hypoglycemia, showing high sensitivity and specificity. While it may lead to overdiagnosis, it

Area of Science:

  • Pediatric Endocrinology
  • Clinical Diagnostics
  • Point-of-Care Testing

Background:

  • Hypoglycemia is a common pediatric condition presenting diagnostic challenges.
  • In resource-limited tropical settings, efficient diagnostic methods are crucial.
  • Evaluating alternative diagnostic tools for hypoglycemia is necessary.

Purpose of the Study:

  • To validate the glucometer method for assessing hypoglycemia in pediatric patients.
  • To compare glucometer readings with laboratory-based glucose determination.
  • To assess the diagnostic accuracy of glucometers in a pediatric population.

Main Methods:

  • Conducted a study with 453 consecutively admitted pediatric patients.
  • Collected blood samples for analysis by both glucometer and laboratory glucose oxidase method.
  • Defined hypoglycemia as plasma glucose < 2.5 mmol/L (<45 mg/dL).

Main Results:

  • Analyzed results from 392 patients; 9.7% were hypoglycemic by glucometer vs. 6.4% by lab.
  • The glucometer demonstrated high sensitivity and specificity.
  • The glucometer showed a positive predictive index of 63.12% and negative of 99.72%, indicating potential overdiagnosis.

Conclusions:

  • The glucometer method shows significant correlation with laboratory results for pediatric blood glucose.
  • High sensitivity and specificity support its use in emergency pediatric cases.
  • The glucometer is a recommended tool for blood sugar determination in children, especially in resource-limited settings.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...